Tech Company Financing Transactions

Colossal Biosciences Funding Round

On 1/31/2023, Colossal Biosciences announced $150 million in Series B funding from private investors, US Innovative Technology Fund and Animal Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Undisclosed
Dallas, TX Undisclosed
USA

Phone

Undisclosed

Website

www.colossal.com

Email Address

Not Recorded

Overview

At Colossal Biosciences, we endeavor to jumpstart nature's ancestral heartbeat. To see the Woolly Mammoth thunder upon the tundra once again. To advance the economies of biology and nutrition. To make humanity more human. And to reawaken the lost wilds of Earth. So we, and our planet, can breathe easier.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Operating Officer

Kent Wakeford

        

Co-Founder

Brian Beard

        

Co-Founder

Andrew Busey

        

Co-Founder

Peter Phillips

        

Founder

George Church

        

Founder

Ben Lamm

        

Browse more venture capital transactions:

Prev: 1/31/2023: Paradigm venture capital transaction
Next: 1/31/2023: Select Star venture capital transaction

Share this article

Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary